Found: 20
Select item for more details and to access through your institution.
Low-Wage Workers and Health Benefits Use: Are We Missing an Opportunity?
- Published in:
- Population Health Management, 2018, v. 21, n. 6, p. 435, doi. 10.1089/pop.2017.0191
- By:
- Publication type:
- Article
High intensity lifestyle intervention and long-term impact on weight and clinical outcomes.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195794
- By:
- Publication type:
- Article
Association of Wage With Employee Participation in Health Assessments and Biometric Screening.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese men.
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 1, p. 84, doi. 10.1111/jdi.12538
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 12, p. 1528, doi. 10.1002/jcph.773
- By:
- Publication type:
- Article
Effects of Age, Sex, and Obesity on the Single-Dose Pharmacokinetics of Omarigliptin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 374, doi. 10.1002/cpdd.255
- By:
- Publication type:
- Article
Synergy at Work: Evidence Development and Assessment of the Business Value of Investments in Workforce Health.
- Published in:
- Population Health Management, 2015, v. 18, n. 3, p. 147, doi. 10.1089/pop.2014.0152
- By:
- Publication type:
- Article
Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist.
- Published in:
- AAPS Journal, 2010, v. 12, n. 4, p. 537, doi. 10.1208/s12248-010-9212-2
- By:
- Publication type:
- Article
CB1 receptor inverse agonist pharmacotherapy for metabolic disorders.
- Published in:
- Drug Development Research, 2009, v. 70, n. 8, p. 566, doi. 10.1002/ddr.20335
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 10, p. 1228, doi. 10.1177/0091270009341651
- By:
- Publication type:
- Article
Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 7, p. 856, doi. 10.1177/0091270009336735
- By:
- Publication type:
- Article
Model-Based Decision Making in Early Clinical Development: Minimizing the Impact of a Blood Pressure Adverse Event.
- Published in:
- AAPS Journal, 2009, v. 11, n. 1, p. 99, doi. 10.1208/s12248-009-9083-6
- By:
- Publication type:
- Article
Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
- Published in:
- Advances in Therapy, 2008, v. 25, n. 11, p. 1175, doi. 10.1007/s12325-008-0116-9
- By:
- Publication type:
- Article
Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, in Healthy Male Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 6, p. 734, doi. 10.1177/0091270008317591
- By:
- Publication type:
- Article
NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine.
- Published in:
- Obesity (19307381), 2007, v. 15, n. 8, p. 2027, doi. 10.1038/oby.2007.242
- By:
- Publication type:
- Article
MK-0364, a Novel Cannabinoid-1 Receptor Inverse Agonist, Increases Energy Expenditure in Overweight and Moderately Obese Subjects.
- Published in:
- Diabetes, 2007, v. 56, p. A461
- By:
- Publication type:
- Article
Clinical Evaluation of Brain CB-1 Receptor Occupancy of a Novel CB-1R Inverse Agonist Using CB-1R PET.
- Published in:
- Diabetes, 2007, v. 56, p. A693
- By:
- Publication type:
- Article
Recombinant Methionyl Human Leptin Administration to Achieve High Physiologic or Pharmacologic Leptin Levels Does Not Alter Circulating Inflammatory Marker Levels in Humans with Leptin Sufficiency or Excess.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 3, p. 1618, doi. 10.1210/jc.2004-1921
- By:
- Publication type:
- Article
Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 3, p. 993, doi. 10.1210/jc.2002-021209
- By:
- Publication type:
- Article
Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active Antiretroviral Therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 2, p. 627, doi. 10.1210/jc.2002-020795
- By:
- Publication type:
- Article